|
Volumn 17, Issue 4, 2008, Pages 231-238
|
Botulinum toxin type A injections for the management of flexion contractures following total knee arthroplasty.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BOTULINUM NEUROTOXIN A (870 1295);
BOTULINUM NEUROTOXIN A (870-1295);
BOTULINUM TOXIN A;
PEPTIDE FRAGMENT;
ADULT;
AGED;
ARTICLE;
CONTRACTURE;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
JOINT CHARACTERISTICS AND FUNCTIONS;
KNEE;
KNEE ARTHROPLASTY;
MALE;
MIDDLE AGED;
PATHOPHYSIOLOGY;
POSTOPERATIVE COMPLICATION;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ARTHROPLASTY, REPLACEMENT, KNEE;
BOTULINUM TOXIN TYPE A;
CONTRACTURE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
KNEE JOINT;
MALE;
MIDDLE AGED;
PEPTIDE FRAGMENTS;
POSTOPERATIVE COMPLICATIONS;
RANGE OF MOTION, ARTICULAR;
TREATMENT OUTCOME;
|
EID: 59449097474
PISSN: 1548825X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (19)
|
References (0)
|